-
Research
-
Media Coverage
In the Spotlight
Unlocking the Potential of Health Data to Help Research and Treatments
Nature ∙ 05/03/2022 ∙ CTSA Program
Medical records can be tricky to access because of confidentiality and variability, but data-sharing efforts are helping to overcome these hurdles — without compromising patient privacy. Spurred by the COVID-19 pandemic, researchers have begun to aggregate data from individual institutions in national repositories that are more accessible. In the United States, the National COVID Cohort Collaborative (N3C) is the largest patient-privacy-limited data set in the country’s history, says Melissa Haendel, who co-leads the effort.
August 2022
-
Social Determinants of Health Are Important Contributors to Mortality Disparities in U.S., Study Finds
Mirage News ∙ 08/12/2022 ∙ CTSA Program -
Betamethasone Could Improve Outcomes for Prostate Cancer Radiation Therapy
Mirage News ∙ 08/12/2022 ∙ CTSA Program -
Study Uses Music to Soothe Dementia Patients and Caregivers
SeniorAu ∙ 08/11/2022 ∙ CTSA Program -
Monoclonal Antibody Decreases Asthma Attacks by 27% in Children and Adolescents of Color
News-Medical.net ∙ 08/10/2022 ∙ CTSA Program -
Better Roadmap for Beating Deadly Leukemia
Mirage News ∙ 08/10/2022 ∙ CTSA Program -
Parental Keratoconus Literacy: A Socioeconomic Perspective
New CryptoCurrency News ∙ 08/09/2022 ∙ CTSA Program -
Early Time-Restricted Eating Ups Weight Loss, but Jury Still Out
Medscape ∙ 08/09/2022 ∙ CTSA Program -
Restricting Eating to Certain Hours Bolsters Weight Loss
TechiLive.in ∙ 08/08/2022 ∙ CTSA Program -
Music Can Benefit People with Alzheimer’s and Caregivers
Futurity ∙ 08/08/2022 ∙ CTSA Program -
Intensity of Football Head Impacts Linked With CTE Risk
MedPage Today, LLC ∙ 08/05/2022 ∙ NCATS -
Hearing Loss Plagues Cancer Survivors No Matter the Type of Chemo
TechiLive.in ∙ 08/04/2022 ∙ CTSA Program -
Mother Says She’s Proud of Toddler’s Uncombable Hair Syndrome
Express Digest ∙ 08/03/2022 ∙ Rare Diseases -
SLFN11's Surveillance Role in Protein Homeostasis
Medical Xpress ∙ 08/03/2022 ∙ Division of Preclinical Innovation -
Exercise Can Improve the Effectiveness of Pancreatic Cancer Treatment
Industry Update ∙ 08/02/2022 ∙ CTSA Program -
Exercise Can Enhance Pancreatic Cancer Treatment
SciTechDaily ∙ 08/02/2022 ∙ CTSA Program -
ISS’s Research on Aging
Federal Telemedicine News ∙ 08/01/2022 ∙ Tissue Chip
July 2022
-
Research Supports Potential of Genome-to-Treatment to Guide Physicians
Mirage News ∙ 07/26/2022 ∙ Division of Preclinical Innovation, GARD -
STRM.BIO Receives $2.1 Million SBIR Grant to Advance Extracellular Vesicle Technology for Non-Viral, In Vivo Delivery of Gene Therapies
NBC12 ∙ 07/26/2022 ∙ SBIR/STIR -
Silent, Subtle and Unseen: How Seizures Happen and Why They're Hard to Diagnose
Yahoo! News ∙ 07/21/2022 ∙ CTSA Program -
Benefits of Physical, Mental Activity on Thinking May Vary for Men and Women, Study Suggests
News-Medical.net ∙ 07/20/2022 ∙ NCATS -
International Space Station National Lab Sponsoring Diverse Set of Experiments on SpaceX CRS-25
West Orlando News ∙ 07/16/2022 ∙ Tissue Chip -
NASA, SpaceX Launch Climate Science Research, More to Space Station
Associated Press ∙ 07/15/2022 ∙ Tissue Chip -
Avrobio Receives Orphan Drug Designation for Hunter Syndrome Gene Therapy
Pharmaceutical Technology ∙ 07/14/2022 ∙ Rare Diseases -
Early Sepsis Control Tied to Lower 90-Day Mortality
MedPage Today, LLC ∙ 07/14/2022 ∙ CTSA Program -
Parents, Community Support Child Stricken With Rare Disorder
The Post-Journal ∙ 07/13/2022 ∙ GARD, Rare Diseases -
Study Shows Convalescent Plasma Does Not Benefit Severely Ill Patients Hospitalized with COVID-19
Chester County Independent (Tennessee) ∙ 07/12/2022 ∙ CTSA Program -
NIH-Funded Tissue Chip Investigations to Fly on SpaceX CRS-25 Mission to the ISS
Parabolic Arc ∙ 07/11/2022 ∙ Tissue Chip -
Children's Book Sold in Port Aransas to Benefit Research on Rare Condition
Corpus Christi Caller Times ∙ 07/11/2022 ∙ GARD -
Study Highlights the Multibillion Dollar Burden of Rare Disease
pharmaphorum ∙ 07/11/2022 ∙ Rare Diseases -
Genetic Variation May Explain Differences in CTE Risk After Repetitive Head Impact
Medscape ∙ 07/11/2022 ∙ CTSA Program -
Major Step Forward in Fabricating an Artificial Heart, Fit for a Human
ScienceDaily ∙ 07/08/2022 ∙ Tissue Chip -
NIH-Funded Tissue Chip Investigations to Fly on SpaceX CRS-25 Mission to the ISS
SpaceRef ∙ 07/08/2022 ∙ Tissue Chip -
The Sino-American Pharmaceutical Professionals Association-Greater Philadelphia (SAPA-GP) Hosted the Inaugural @Philly Cell and Gene Therapy Annual Conference
Associated Press ∙ 07/08/2022 ∙ Bespoke Gene Therapy Consortium
June 2022
-
This Clinical Trial Wanted to End Breast Cancer Disparities. But First It Needed to Enroll Black Women
STAT ∙ 06/30/2022 ∙ CTSA Program -
What is Bjornstad Syndrome?
Archynetys ∙ 06/30/2022 ∙ GARD -
Light During Sleep in Older Adults Linked to Obesity, Diabetes, High Blood Pressure
Mirage News ∙ 06/28/2022 ∙ CTSA Program -
Mixed Bag for Semaglutide in NASH-Related Compensated Cirrhosis
MedPage Today, LLC ∙ 06/27/2022 ∙ NCATS -
Certified Stroke Care Access May Be Reduced for Black Americans
MedPage Today, LLC ∙ 06/27/2022 ∙ CTSA Program -
Modeling a Devastating Childhood Disease on a Chip: Environmental Enteric Dysfunction (EED) Chip Reveals Effects of Nutrition and Genetics on Disease in Children
TechiLive.in ∙ 06/25/2022 ∙ CTSA Program -
Misinformation Will Be Rampant When It Comes to COVID-19 Shots for Young Children – Here's What You Can Do to Counter It
Yahoo! News ∙ 06/24/2022 ∙ CTSA Program -
NCATS’ “Many-Diseases-at-a-Time” Approach to Gene Therapy
CheckRare ∙ 06/24/2022 ∙ Rare Diseases -
Creating a Safe Space for IoT
Federal News Network ∙ 06/21/2022 ∙ NCATS -
Immune Modulator Drugs Improved Survival for People Hospitalized with COVID-19
POZ ∙ 06/21/2022 ∙ CTSA Program -
Denver Nurse Turns Patient, Learns from Being on the Receiving End of Caregiving
KDVR ∙ 06/19/2022 ∙ GARD -
Has the COVID-19 Pandemic Impacted Flu Shot Uptake?
Precision Vaccinations ∙ 06/17/2022 ∙ CTSA Program -
Miracle Pill Paxlovid Benched as the People’s Antivirals Ivermectin & Tollovid Sub In
ZeroHedge.com/ABC Media, Ltd. ∙ 06/17/2022 ∙ CTSA Program -
UCLA Study Finds Factors Causing Low COVID-19 Vaccination Rates Have Spilled Over to Lower Flu Vaccination Rates
Sierra Sun Times ∙ 06/17/2022 ∙ CTSA Program -
Sensor-Equipped Computer Program Tracks the Patients' Arm Movements During Stroke Rehabilitation
News-Medical.net ∙ 06/16/2022 ∙ CTSA Program -
Synthetic Opioid Use Up Almost 800% Nationwide
Medscape ∙ 06/15/2022 ∙ CTSA Program -
Factors Causing Low COVID-19 Vaccination Have Spilled Over to Lower Flu Vaccination Rates, Study Finds
ScienceDaily ∙ 06/15/2022 ∙ CTSA Program -
VA Adds Nine Rare Cancers to Presumed Service-Connected Disabilities
U.S. Medicine ∙ 06/12/2022 ∙ GARD, Rare Diseases -
Characteristics of Long COVID
RT Magazine ∙ 06/10/2022 ∙ CTSA Program -
Santhera and ReveraGen to Present New Data with Vamorolone at 2022 Parent Project Muscular Dystrophy Conference
Yahoo! Finance ∙ 06/09/2022 ∙ NCATS -
How Might Chimeric, Droplet-Forming Proteins Contribute to Cancer?
Nation World News ∙ 06/06/2022 ∙ NCATS -
OSU Studies: Third Booster Provides Strong Protection against Variants
The Daily Legal News ∙ 06/06/2022 ∙ NCATS -
Immune Modulator Drugs Improved Survival for People Hospitalized with Covid
Mirage News ∙ 06/03/2022 ∙ NCATS -
Hillstream BioPharma Provides Corporate Update
Yahoo! Finance ∙ 06/02/2022 ∙ NCATS -
Bristol Myers Squibb Announces Topline Results Showing Treatment with Orencia (abatacept) Improved Survival in People Hospitalized with COVID-19
Associated Press ∙ 06/02/2022 ∙ CTSA Program -
Q&A: Machine Learning Models Identify Patients with Long COVID
Healio ∙ 06/01/2022 ∙ CTSA Program -
Unnecessary Antibiotics Do Kids More Harm than Good
Futurity ∙ 06/01/2022 ∙ CTSA Program
May 2022
-
Serum Pepsinogen Is Associated with Gastric Cancer Risk
MDedge Hematology and Oncology ∙ 05/22/2022 ∙ CTSA Program -
NIH Announces Antiviral Drug Development Awards
PHARMABIZ.com ∙ 05/20/2022 ∙ Division of Preclinical Innovation -
MELD Scoring for Liver Transplants in Need of Sex Adjustment, Study Says
TechiLive.in ∙ 05/19/2022 ∙ CTSA Program -
COVID Booster Needed for Broad Protection against Omicron Variants
ScienceDaily ∙ 05/18/2022 ∙ CTSA Program -
NIH Awards $577 Million to Establish AViDD Centers for Pathogens of Pandemic Concern
News-Medical.net ∙ 05/18/2022 ∙ Division of Preclinical Innovation -
2022 FedHealthIT Innovation Award Winners
FedHealthIT ∙ 05/17/2022 ∙ NCATS -
Widely Available AI Could Have Deadly Consequences
WIRED ∙ 05/17/2022 ∙ Division of Preclinical Innovation -
Scientists Identify Characteristics to Better Define Long COVID: Using Machine Learning, Researchers Find Patterns in Electronic Health Record Data to Better Identify Those Likely to Have the Condition
TechiLive.in ∙ 05/17/2022 ∙ CTSA Program -
Smartwatches and Fitness Bands Reveal Individual Physiological Responses to COVID-19 Vaccine
Travors ∙ 05/12/2022 ∙ CTSA Program -
HAIP Chemotherapy or Resection for Multifocal Bile Duct Cancer?
TechiLive.in ∙ 05/12/2022 ∙ NCATS -
Do COVID Vaccines Stave Off New Medical Conditions?
TechiLive.in ∙ 05/10/2022 ∙ CTSA Program -
Here are Federal Agencies' Steps to IOT Adoption
GovernmentCIO Media & Research ∙ 05/09/2022 ∙ NCATS -
Use Case Show Translator’s Potential to Expedite Clinical Research
RENCI ∙ 05/04/2022 ∙ Biomedical Data Translator -
Unlocking the Potential of Health Data to Help Research and Treatments
Nature ∙ 05/03/2022 ∙ CTSA Program
April 2022
-
Insulin Spray Improved Gait, Cognitive Function in Patients with and without Type 2 Diabetes, Clinical Trial Shows
Mirage News ∙ 04/30/2022 ∙ CTSA Program -
Ridner Concludes Five-Year, Multi-Site Trial to Assess Lymphedema Prevention
Mirage News ∙ 04/29/2022 ∙ CTSA Program -
Researchers Test the Power of Machine Learning to Unravel Long Covid’s Mysteries
STAT ∙ 04/29/2022 ∙ CTSA Program -
EPA Posts Presentations from Meeting on New Chemicals Collaborative Research Program
The National Law Review ∙ 04/27/2022 ∙ Division of Preclinical Innovation -
Synthetic Data Accurately Replicates the Results of Analyses from Real COVID-19 Patient Data
News-Medical.net ∙ 04/27/2022 ∙ CTSA Program -
Team Wins Global Competition to Develop Next-Gen Tools, Improve Public Health Solutions
Mirage News ∙ 04/26/2022 ∙ NCATS -
Hydrocortisone Ineffective against Bronchopulmonary Dysplasia in Extremely Preterm Infants
RT Magazine ∙ 04/26/2022 ∙ CTSA Program -
Panel Discussion: The High Cost of Rare Diseases
MasupMD ∙ 04/25/2022 ∙ Rare Diseases -
EPA Holds Meeting on TSCA New Chemicals Collaborative Research Program
The National Law Review ∙ 04/22/2022 ∙ Division of Preclinical Innovation -
Scientists Find Digital Biomarkers That May Be Associated with Vaccine-Induced Immune Responses
Jioforme.com ∙ 04/20/2022 ∙ CTSA Program -
Smartwatches and Fitness Bands Reveal Individual Physiological Responses to Covid Vaccine
Mirage News ∙ 04/20/2022 ∙ CTSA Program -
Researchers Create 3-D Model for Rare Neuromuscular Disorders, Setting Stage for Clinical Trial
Mirage News ∙ 04/20/2022 ∙ SBIR/STIR, Tissue Chip -
Why Cheap, Older Drugs That Might Treat Covid Never Get Out of the Lab
Kaiser Health News ∙ 04/19/2022 ∙ NCATS -
New Covid Nasal Spray Outperforms Current Antibody Treatments in Mice
Mirage News ∙ 04/14/2022 ∙ Tissue Chip -
What is Birt-Hogg-Dube Syndrome?
News-Medical.net ∙ 04/14/2022 ∙ GARD -
A Promising Natural Alternative for Estrogen Deficiency
WFMZ ∙ 04/13/2022 ∙ NCATS -
What Is Myotonic Dystrophy (DM)?
WebMD ∙ 04/13/2022 ∙ NCATS -
Research in Human Kidney Organoids Finds Target to Prevent Irreversible Kidney Damage
Mirage News ∙ 04/12/2022 ∙ CTSA Program -
Is Alzheimer’s Risk Lower with TNF Inhibitors?
TechiLive.in ∙ 04/09/2022 ∙ NCATS -
Poverty-Related Stress Linked to Aggressive Head and Neck Cancer
MDedge Federal Practitioner ∙ 04/08/2022 ∙ CTSA Program -
Scientists and Communicators Team Up to Increase Clinical Trial Participation
Drug Discovery News ∙ 04/08/2022 ∙ CTSA Program -
Researchers Identify Gene That Predicts Breast Cancer Patients’ Treatment Outcomes
Let Life Happen ∙ 04/04/2022 ∙ CTSA Program
March 2022
-
Examining the Burden of Rare Diseases in the US
Open Access Government ∙ 03/31/2022 ∙ GARD -
BabySeq Newborn Screening Project Aims for Increased Diversity in Second Phase
GenomeWeb ∙ 03/31/2022 ∙ NCATS -
Ivermectin Does Not Reduce Risk of Covid Hospitalization, Large Study Finds
The New York Times ∙ 03/30/2022 ∙ CTSA Program -
Early Use of High-Titer Plasma Reduced COVID Hospitalizations
MedPage Today, LLC ∙ 03/30/2022 ∙ CTSA Program -
Patients Report Neuropathy after COVID-19
Futurity ∙ 03/30/2022 ∙ CTSA Program -
Symptoms Persisted for Months after a Positive Test For COVID-19
Verve Times ∙ 03/26/2022 ∙ CTSA Program -
Study Find Links Between Inflammation, Menopause, and Depressive Disorder
Verified News Explorer Network ∙ 03/25/2022 ∙ CTSA Program -
Diet’s Effect on Gut Bacteria Could Play Role in Reducing Alzheimer’s Risk
Verified News Explorer Network ∙ 03/25/2022 ∙ CTSA Program -
Alternative Medicine is Widespread among People with Multiple Sclerosis
Verified News Explorer Network ∙ 03/25/2022 ∙ CTSA Program -
Inflammation Seen in Earliest Stages of Parkinson’s Disease, and It Is Different between Men and Women
Verified News Explorer Network ∙ 03/25/2022 ∙ CTSA Program -
An Itch to Scratch: Potential Approach to Chronic Itch Problem Identified
Verified News Explorer Network ∙ 03/25/2022 ∙ ADST -
Imbalance in Gum Bacteria Linked to Alzheimer’s Disease Biomarker
Verified News Explorer Network ∙ 03/25/2022 ∙ CTSA Program -
Implantable Biotech Shows Promise in War on Cancer, Say NCSU, UNC Researchers
WRAL TechWire ∙ 03/25/2022 ∙ CTSA Program -
Drug Reverses Age-Related Cognitive Decline within Days
Verified News Explorer Network ∙ 03/25/2022 ∙ CTSA Program -
Artificial Intelligence Algorithm Can Accurately Predict Risk and Diagnose Alzheimer’s Disease
Verified News Explorer Network ∙ 03/25/2022 ∙ CTSA Program -
Study Explores Sleep Apnea, Autoimmune Disease Link
Verified News Explorer Network ∙ 03/25/2022 ∙ CTSA Program -
Low-Carb ‘Keto’ or ‘Atkins-Style’ Diet May Modestly Improve Cognition in Older Adults
Verified News Explorer Network ∙ 03/25/2022 ∙ CTSA Program -
How Advancing Glioma Cells Scramble Brain Function and Blood Flow
Verified News Explorer Network ∙ 03/25/2022 ∙ CTSA Program -
Here’s How Migraine with Aura Can Affect Your Vision, Muscles, and Speech
MSN ∙ 03/24/2022 ∙ GARD -
Researchers Identify Gene That Predicts Breast Cancer Patients' Treatment Outcomes
Medindia ∙ 03/24/2022 ∙ CTSA Program -
Biomedical Data Platform Moves to the Next Phase
RENCI ∙ 03/24/2022 ∙ Biomedical Data Translator -
Shock to the System: Pediatric Type 1 Diabetes Patients and Trauma
Endocrine News ∙ 03/23/2022 ∙ CTSA Program -
Angiotensin-Converting Enzyme 2 Allosteric Binders Found to Be Effective against SARS-CoV-2
News-Medical.net ∙ 03/22/2022 ∙ NCATS -
A 31-Year-Old Female Presented with a Burning Rash on Upper Arms, Groin, and Axillae
MDedge Dermatology ∙ 03/17/2022 ∙ GARD -
Can We Streamline How AAV Gene Therapies Are Developed?
CheckRare ∙ 03/17/2022 ∙ Rare Diseases -
RaDaR Serves as Starting Point for Creating Rare Disease Registry
BioNews, Inc. ∙ 03/16/2022 ∙ Rare Diseases -
Painkillers That Don’t Kill
Livdose ∙ 03/14/2022 ∙ Division of Preclinical Innovation, Stem Cell Translation Laboratory -
Fundraiser to Provide Van for Child in Need
Oxford Observer ∙ 03/14/2022 ∙ GARD -
A Woman Found Out through Instagram Her Son Had Uncombable Hair Syndrome. But What Is It?
USA Today ∙ 03/11/2022 ∙ GARD -
Keto Diet in MS Tied to Less Disability, Better Quality of Life
Medscape ∙ 03/10/2022 ∙ NCATS -
Continuing Face Mask Use Could Save U.S. Billions of Dollars
Mirage News ∙ 03/09/2022 ∙ CTSA Program -
Blunt Secures 7th Consecutive Increase for Life-Saving, Cost-Saving NIH Research
Public Technologies Inc. ∙ 03/09/2022 ∙ CTSA Program -
Maintaining Face Mask Use for Short Time after Hitting Particular COVID-19 Vaccination Targets Offers Major Economic and Health Benefits, Modelling Indicates
The Lancet ∙ 03/08/2022 ∙ CTSA Program -
Study Shows Structural Racism Can Result in Poorer Leukemia Outcomes
ReachMD ∙ 03/08/2022 ∙ CTSA Program -
New Dental Tool Prototype Can Spot the Acidic Conditions That Lead to Cavities
ScienceDaily ∙ 03/08/2022 ∙ NCATS -
Program Awardees: Disruptive Tech Summit – Change Agents Shifting the Landscape
G2Xchange FedCiv ∙ 03/08/2022 ∙ CTSA Program -
Study Maps Neural Pathways for Migraine Pain, Identifies Two Potential CGRP Treatments
Practical Pain Management ∙ 03/07/2022 ∙ Division of Preclinical Innovation -
Kidney Disease Gene Risk Info Aids Prevention in Primary Care
MedPage Today, LLC ∙ 03/04/2022 ∙ CTSA Program -
Pregnant Women Have Lingering Depression, Anxiety – Even With Antidepressant Treatment
24HTECH.ASIA ∙ 03/04/2022 ∙ CTSA Program -
U of M Researchers Find Cohorting Patient Care Model during Pandemic Improved Patient Outcomes
Mirage News ∙ 03/04/2022 ∙ CTSA Program -
Children Affected by Educational Disruptions Experience Mental Health Declines
Pharmacy Times ∙ 03/03/2022 ∙ CTSA Program -
Cohorting Patient Care Model during Pandemic Improved Patient Outcomes, Researchers Find
ScienceDaily ∙ 03/03/2022 ∙ CTSA Program -
UAMS Receives National Accreditation for Clinical Informatics Fellowship Program
Log Cabin Democrat ∙ 03/01/2022 ∙ CTSA Program -
Ketogenic Diet May Reduce Disability, Improve Quality of Life in People with MS
Associated Press ∙ 03/01/2022 ∙ NCATS
February 2022
-
AFCEA Panel Tackles Vital Issues
Federal Telemedicine News ∙ 02/28/2022 ∙ CTSA Program, Division of Preclinical Innovation -
World Rare Disease Day 2022 — “Sharing Your Colours!”
Medindia ∙ 02/28/2022 ∙ Rare Diseases -
Rare Disease Day: Updates on Rare Neurological Diseases
https://www.neurologylive.com/view/rare-disease-day-updates-on-rare-neurological-diseases ∙ 02/28/2022 ∙ GARD -
Rare Disease Day 2022 – A Day to Embrace Innovation (and Wear Your Stripes)
CheckRare ∙ 02/26/2022 ∙ Rare Diseases, RDCRN, TRND -
National Youth COVID Study Could Speed Care for Sickest Children
Biz News Post ∙ 02/26/2022 ∙ CTSA Program -
Update on FDA Adjustment to Evusheld Dosage Regimen in US
Drugs.com ∙ 02/25/2022 ∙ Division of Preclinical Innovation -
UF Health Jacksonville: COVID-19 Trial Studying Effectiveness of Ivermectin, 2 Other Drugs
jacksonville.com ∙ 02/25/2022 ∙ CTSA Program -
Trial Innovation Network Provides Resources for Investigators – UB Now: News and Views for UB Faculty and Staff
Zipe-Education ∙ 02/24/2022 ∙ CTSA Program -
JACC: High Coronary Artery Calcium, High Cholesterol Increase Heart Attack/Stroke Risk
HMP Global ∙ 02/24/2022 ∙ NCATS -
Plant-Based Meat Alternatives Growing but Not Enough to Impact Beef Industry
Phys.org ∙ 02/24/2022 ∙ CTSA Program -
The Post-Pandemic Life Sciences Landscape: How a Crisis Enabled Innovation, Collaboration and a New Way Forward
SmartBrief ∙ 02/22/2022 ∙ CTSA Program -
UVA Health Studies Ivermectin, Fluvoxamine to Treat COVID-19
InsideNoVa.com ∙ 02/21/2022 ∙ CTSA Program -
UVA Participates in Study to Test Controversial Drug for COVID Treatment, Could Have 'Huge Global Impact'
WUSA9.com ∙ 02/21/2022 ∙ CTSA Program -
The Assistance Fund Opens New Program for Cold Agglutinin Disease
Newswire ∙ 02/21/2022 ∙ GARD -
UVA Health Joins National Trial Testing Medications for Mild to Moderate Covid
Mirage News ∙ 02/21/2022 ∙ CTSA Program -
Children with Insomnia Likely to Continue to Suffer as Adults
24 ∙ 02/18/2022 ∙ NCATS -
More Studies Confirm Hefty Economic Burden of Rare Diseases
Muscular Dystrophy News ∙ 02/17/2022 ∙ Rare Diseases -
Defining Clinical Outcome Pathways
Drug Discovery Today ∙ 02/16/2022 ∙ Biomedical Data Translator -
NIH-Backed Nasal Nonaddictive Pain Prospect Clears Early Test
FiercePharma ∙ 02/15/2022 ∙ NCATS -
Hillstream BioPharma Provides Business Review with Key Pipeline Updates
Yahoo! Finance ∙ 02/14/2022 ∙ NCATS -
Novel Melatonin Receptor Molecules Make Possible Therapies to Adjust Biological Clock
Verified News Explorer Network ∙ 02/14/2022 ∙ CTSA Program -
Craving Junk Food after a Sleepless Night?
Verified News Explorer Network ∙ 02/14/2022 ∙ CTSA Program -
The Relationship between Looking and Listening and Human Emotions
Verified News Explorer Network ∙ 02/14/2022 ∙ NCATS -
Autonomous Biohybrid Fish – Made from Human Cardiac Cells – Swims Like the Heart Beats
SciTechDaily ∙ 02/11/2022 ∙ Tissue Chip -
Panel Discussion: The High Cost of Rare Diseases
CheckRare ∙ 02/11/2022 ∙ Rare Diseases -
Biomarkers Predict Cardiovascular Risk in Chronic Kidney Disease Patients
Medscape ∙ 02/11/2022 ∙ CTSA Program -
Virpax Touts Study Results for Intranasal Spray for Treating Acute, Chronic Pain
Drug Delivery Business News ∙ 02/10/2022 ∙ NCATS -
Screening Assays Identify TMPRSS2 Inhibitors from Drug Repurposing Candidates Useful as COVID-19 Therapeutic
News-Medical.net ∙ 02/10/2022 ∙ Division of Preclinical Innovation -
Which Kids Are More Likely to Develop MIS-C?
TechiLive.in ∙ 02/09/2022 ∙ CTSA Program -
Researchers Identify a Potent New Combination of Antiviral Drugs to Combat SARS-CoV-2
News-Medical.net ∙ 02/09/2022 ∙ Division of Preclinical Innovation -
Breast Boils: What They Are, How to Treat Them
HealthCentral ∙ 02/08/2022 ∙ Rare Diseases -
Association between Hormonal Birth Control, Substance Use, and Depression
Frontiers in Psychiatry ∙ 02/08/2022 ∙ CTSA Program -
Top 5 Startups Enhancing Drug Discovery Using AI and Machine Learning
GreyB Services ∙ 02/07/2022 ∙ NCATS -
Pregnant Women with COVID-19 May Be at Greater Risk for Pregnancy Complications
News-Medical.net ∙ 02/07/2022 ∙ CTSA Program -
Novel Biosensor Detects Biomarkers Tied to Traumatic Brain Injuries
AZoSensors.com ∙ 02/04/2022 ∙ CTSA Program -
Findings Link Migraine Pain to Schwann Cells
Futurity ∙ 02/04/2022 ∙ NCATS -
COVID-19: Study Finds Narrow Window for Convalescent Plasma Effectiveness
MedicalResearch.com ∙ 02/03/2022 ∙ CTSA Program -
Humans and Other Primates Have Evolved Less Sensitive Noses
PLoS ∙ 02/03/2022 ∙ CTSA Program -
Scientists Test Promising Biosensor Aimed for Use in Brain
ScienceDaily ∙ 02/03/2022 ∙ CTSA Program -
Possible New Method Identified to Assess Severity of TB Infection
Mirage News ∙ 02/03/2022 ∙ CTSA Program -
Study Reveals How Migraine Pain Signals Are Generated—and Blocked
Medical Xpress ∙ 02/03/2022 ∙ NCATS -
Transition to Federal Health Data Standards an ‘Unfunded Mandate’ for Smaller Providers
FedScoop ∙ 02/01/2022 ∙ NCATS -
Why Each Alzheimer's Patient is Different
Alzheimer's & Dementia Weekly ∙ 02/01/2022 ∙ CTSA Program
January 2022
-
Researchers Identify a New Protein That Enables SARS-CoV-2 Access into Cells: Findings May Lead to the Development of New Antiviral Therapeutics against COVID-19
TechiAI ∙ 01/28/2022 ∙ CTSA Program -
Hypertensive Crisis: Uncontrolled Blood Pressure Is Sending Twice as Many People to the Hospital
24HTECH.ASIA ∙ 01/27/2022 ∙ CTSA Program -
Hypertensive Crisis: Uncontrolled Blood Pressure Is Sending Twice as Many People to the Hospital
SciTechDaily ∙ 01/27/2022 ∙ CTSA Program -
Tool Pinpoints Who May Benefit from COVID Convalescent Plasma
TechiLive.in ∙ 01/27/2022 ∙ CTSA Program -
UAMS Research Team Finds COVID-19 Has Mutation Limits
Log Cabin Democrat ∙ 01/26/2022 ∙ CTSA Program -
Let’s Break Down the New Cannabis and COVID-19 Research
MSN ∙ 01/26/2022 ∙ CTSA Program -
SpaceX CRS-24 Splashes Down Safely after One Month on the ISS, Returns Science to Researchers on Earth
SpaceRef ∙ 01/25/2022 ∙ Tissue Chip -
Local Startup Lands NIH Grant for 3D-printing Collaboration with Virginia Tech
American City Business Journals ∙ 01/25/2022 ∙ SBIR/STIR -
New Study Validates Benefits of Convalescent Plasma for Some COVID-19 Patients
ScienceDaily ∙ 01/25/2022 ∙ CTSA Program -
Phase and Virginia Tech Partner to Advance Microfluidic 3D Printing
3D Printing Industry ∙ 01/25/2022 ∙ SBIR/STIR -
Men Who Worry More May Develop Heart Disease and Diabetes Risk Factors at Younger Ages
Yahoo! Finance ∙ 01/24/2022 ∙ CTSA Program -
COVID Treatments: Essentia Health to Help Test 3 Existing Medications — Including Ivermectin
NewsBreak ∙ 01/24/2022 ∙ NCATS -
Find Predictors of Heart Disease among Black Americans That Are Shared across Ethnicities
HealthNewsDigest.com ∙ 01/24/2022 ∙ CTSA Program -
Why Scientists Are Racing to Develop More COVID Antivirals
Nature ∙ 01/21/2022 ∙ Division of Preclinical Innovation -
Should Alcohol Have Warning Labels about Cancer Risk? Most Americans Say ‘Yes’
Mirage News ∙ 01/21/2022 ∙ CTSA Program -
How Advancing Glioma Cells Scramble Brain Function and Blood Flow
24HTECH.ASIA ∙ 01/19/2022 ∙ CTSA Program -
E-Cigarette Users Who Test Positive for COVID-19 More Likely to Feel Symptoms, Study Says
Winston-Salem Journal ∙ 01/19/2022 ∙ CTSA Program -
Immune Dysfunction Linked to 'Substantial Risk' for Breakthrough COVID-19 Infection
Healio Rheumatology ∙ 01/19/2022 ∙ CTSA Program -
Disrupted Circadian Rhythms Linked to Later Parkinson’s Diagnoses
24HTECH.ASIA ∙ 01/19/2022 ∙ CTSA Program -
Artificial Intelligence Algorithm Can Accurately Predict Risk and Diagnose Alzheimer’s Disease
24HTECH.ASIA ∙ 01/19/2022 ∙ CTSA Program -
Everyday Stress May Boost Blood Vessel Dysfunction in People with Depression
24HTECH.ASIA ∙ 01/19/2022 ∙ CTSA Program -
Update on Agreement to Supply US with Additional Doses of Evusheld, a Long-Acting Antibody Combination
Executive Bulletin ∙ 01/19/2022 ∙ CTSA Program -
Study Finds Vapers More Likely to Experience Heightened COVID Symptoms
La Crosse Tribune ∙ 01/18/2022 ∙ CTSA Program -
Survival Rate Increases for Extremely Preterm Infants in NIH-Funded Research Network
Mirage News ∙ 01/18/2022 ∙ NCATS -
Two Halves of the Hippocampus Have Different Gene Activity
24HTECH.ASIA ∙ 01/17/2022 ∙ CTSA Program -
Key Genes in the Brain Involved in Encoding Memories Identified
24HTECH.ASIA ∙ 01/17/2022 ∙ CTSA Program -
Do You Smell What I Smell?
24HTECH.ASIA ∙ 01/17/2022 ∙ CTSA Program -
Accelerated Cellular Aging Associated with Mortality Seen in Depressed Individuals
24HTECH.ASIA ∙ 01/17/2022 ∙ CTSA Program -
Blocking Protein Curbs Memory Loss in Old Mice
24HTECH.ASIA ∙ 01/17/2022 ∙ CTSA Program -
Public Health Is Missing Crucial Data on LGBTQIA+ People. It’s Not Hard to Collect
STAT ∙ 01/14/2022 ∙ CTSA Program -
ALERT: 2030 Psychological Agenda – Obedience Training for PreK-Adults Already Global with Billions in Funding for Full Control – Part 3: Spirituality In Education Programming
Equal Opportunity Today ∙ 01/14/2022 ∙ CTSA Program -
NIH Sources Sought: NCATS Scientific and Technology Support Services (STSS)
FedHealthIT ∙ 01/13/2022 ∙ NCATS -
A New Approach to Train the Brain to Treat Chronic Pain
Psychology Today ∙ 01/13/2022 ∙ NCATS -
Teaching Old Drugs New Tricks to Treat COVID-19
Nature Synthesis ∙ 01/12/2022 ∙ Division of Preclinical Innovation -
How Rare Disease Research Benefits Everyone
Raconteur ∙ 01/11/2022 ∙ Rare Diseases -
This Is Your Brain in Microgravity Image: NASA
PlasticsToday ∙ 01/11/2022 ∙ Tissue Chip -
Can a Kidney Failure Risk Equation Better Predict ESKD, Regardless of Race?
Physician’s Weekly ∙ 01/11/2022 ∙ NCATS -
UCLA-Led Team May Have Found Way to Kill HIV-Infected Cells
KNX News 97.1 FM ∙ 01/10/2022 ∙ CTSA Program -
Gene Therapies for Rare Diseases
Federal Telemedicine News ∙ 01/10/2022 ∙ Bespoke Gene Therapy Consortium -
More Evidence Ties Some Antipsychotics to Increased Breast Cancer Risk
Let Life Happen ∙ 01/05/2022 ∙ CTSA Program -
Even Healthy Black and Hispanic Women Have More Cesareans than White Women
MDedge ObGyn ∙ 01/04/2022 ∙ CTSA Program -
Convalescent Plasma May Keep Covid-19 Patients Out of Hospital
Futurity ∙ 01/04/2022 ∙ CTSA Program -
Effectiveness and Scalability of an Electronic Patient-Reported Outcome Measure and Decision Support Tool for Family-Centred and Participation-Focused Early Intervention: PROSPECT Hybrid Type 1 Trial Protocol
Healthcare Newsdesk ∙ 01/04/2022 ∙ CTSA Program -
Diagnostic Odyssey: The Lonely Road Walked by Thousands of Coloradans with Rare Disorders
The Gazette ∙ 01/02/2022 ∙ Rare Diseases
December 2021
-
‘Test-to-Stay,’ Children and Staff Can Safely Remain in School After COVID Exposures
HealthNewsDigest.com ∙ 12/30/2021 ∙ CTSA Program -
Which Groups Are the Most Vulnerable to Breakthrough Covid-19 Infection?
Forbes ∙ 12/30/2021 ∙ CTSA Program -
Gene Therapy is Fighting Rare Diseases in FDA, NIH Program
GovernmentCIO Media & Research ∙ 12/29/2021 ∙ Rare Diseases -
With ‘Test-to-Stay,’ Children and Staff Can Safely Remain in School After COVID Exposures
The ABC Science Collaborative ∙ 12/29/2021 ∙ CTSA Program -
Emulate's Organs-on-a-chip Head to the International Space Station to Study Gravity's Pull on the Brain
FierceBiotech ∙ 12/29/2021 ∙ Tissue Chip -
Immunocompromised at Higher Risk of COVID Breakthrough Infection: Study
ABC News ∙ 12/28/2021 ∙ CTSA Program -
A Patient-First Approach to Specialty Pharmacy
Pharmacy Practice News ∙ 12/23/2021 ∙ GARD -
During a COVID-19 Surge, ‘Crisis Standards of Care’ Involve Excruciating Choices and Impossible Ethical Decisions for Hospital Staff
Entrepreneur Media, Inc. ∙ 12/22/2021 ∙ NCATS -
Evusheld Long-Acting Antibody Combination Retains Neutralising Activity against Omicron Variant in Independent FDA Study
PharmiWeb ∙ 12/21/2021 ∙ CTSA Program -
Early Use of Convalescent Plasma May Help Outpatients with COVID-19 Avoid Hospitalization
Yahoo! Finance ∙ 12/21/2021 ∙ CTSA Program -
Emulate Brain-Chip to Study the Effects of Microgravity on Human Brain Physiology at the International Space Station
Yahoo! Finance ∙ 12/21/2021 ∙ Tissue Chip -
Bias, Clinical Inertia May Help Explain Racial Disparities in BP Control
Medscape ∙ 12/21/2021 ∙ CTSA Program -
Boost for NC Gene Therapy Companies – A New Rare Disease Consortium
WRAL TechWire ∙ 12/20/2021 ∙ Bespoke Gene Therapy Consortium, Rare Diseases -
Dr. Anne Pariser Provides an Overview of NIH’s Office of Rare Diseases Research
CheckRare ∙ 12/20/2021 ∙ Rare Diseases -
The FDA Modernization Act Can Leverage Technology to Accelerate Drug Discovery and Save Millions of Animals
Forbes ∙ 12/20/2021 ∙ NCATS -
Evusheld Long-Acting Antibody Combination Retains Neutralising Activity against Omicron Variant in Independent FDA Study
World Pharma News ∙ 12/17/2021 ∙ CTSA Program -
Study Questions Widely Used Race-Based Formula to Define Lung Disease
Mirage News ∙ 12/17/2021 ∙ CTSA Program -
ALS Incidence Higher in NFL Players
Physician’s Weekly ∙ 12/17/2021 ∙ CTSA Program -
Women Who Practise Self-Compassion Have Lower Risk of Cardiovascular Disease
St Louis News.Net ∙ 12/17/2021 ∙ CTSA Program -
Prenatal Insomnia: Digital Therapy Can Prevent Postpartum Depression
Medindia ∙ 12/17/2021 ∙ CTSA Program -
EVUSHELD Long-Acting Antibody Combination Retains Neutralizing Activity against Omicron Variant in Independent FDA Study
Yahoo! Finance ∙ 12/16/2021 ∙ CTSA Program -
The Best Way to Protect Personal Biomedical Data from Hackers Could Be to Treat the Problem Like a Game
Metropolitan Digital ∙ 12/16/2021 ∙ CTSA Program -
SpaceX CRS-24 Launching Multiple Life Science Investigations to International Space Station
Parabolic Arc ∙ 12/16/2021 ∙ Tissue Chip -
SLAS Discovery’s December Special Issue, “Assay Guidance Manual for Drug Discovery: Robust or Go Bust” Available Now
Newswise, Inc. ∙ 12/15/2021 ∙ Division of Preclinical Innovation -
More Evidence Ties Some Antipsychotics to Increased Breast Cancer Risk
Medscape ∙ 12/14/2021 ∙ NCATS -
Therapeutic Enzymes Market 2021: Growth Report Explores Industry Trends, Size, Share & Analysis to 2027 with Dominant Countries Data
openPR ∙ 12/14/2021 ∙ GARD, Rare Diseases -
Not So Rare Diseases: The Cumulative Burden of Underdiagnosis
Pharmafile ∙ 12/14/2021 ∙ Rare Diseases -
Researchers of CONTAIN Study Say Convalescent Plasma Likely Had Benefit in Early Days of COVID-19; Could Be Used Early in Next Pandemic
ScienceDaily ∙ 12/13/2021 ∙ CTSA Program -
LitCoin NLP Challenge by NCATS & NASA
Towards Data Science ∙ 12/10/2021 ∙ NCATS -
New CBD Nasal Spray to Target Seizures in Epilepsy
Cannabis Health ∙ 12/09/2021 ∙ NCATS -
Antipsychotic Drugs May Increase Risk Of Breast Cancer – Washington University School Of Medicine In St. Louis
Pediatric Daily News ∙ 12/06/2021 ∙ CTSA Program -
UAB Scientists Are on Search for the ‘Unknown Known’
Alabama NewsCenter ∙ 12/05/2021 ∙ Biomedical Data Translator -
Digital Therapy for Prenatal Insomnia May Prevent Postpartum Depression
Mirage News ∙ 12/04/2021 ∙ CTSA Program -
iTHRIV Grants Target Obesity among Latinx Youth, Hepatitis C
Augusta Free Press ∙ 12/04/2021 ∙ CTSA Program -
After Recovery from Severe COVID-19, Patients Have Greater Risk of Death, UF Study Finds
Yahoo! News ∙ 12/02/2021 ∙ CTSA Program -
As Omicron Spread Looms, Oral Antivirals Appear to Be One of the Best Defenses — Now We Just Need More
Endpoints News ∙ 12/02/2021 ∙ Division of Preclinical Innovation -
New Studies Predict How SARS-CoV-2 Mutants Can Evade Vaccines – Harvard Gazette
ExBulletin ∙ 12/02/2021 ∙ CTSA Program -
Non–Health Care Municipal Services Cut Severe Maternal Morbidity Rates
Medscape ∙ 12/02/2021 ∙ CTSA Program -
UF: Mortality Rate Higher after Severe COVID Bout
Mainstreet Daily News ∙ 12/01/2021 ∙ CTSA Program -
Preeclampsia Ups Womens’ Risks of HFpEF, HFrEF
Physician’s Weekly ∙ 12/01/2021 ∙ CTSA Program -
Doctors Treat Girl’s Genetic Disorder with Repurposed Drug
The Scientist ∙ 12/01/2021 ∙ Rare Diseases -
Dr Anne Pariser Provides an Overview of NIH’s Office of Rare Diseases Research
CheckRare ∙ 12/01/2021 ∙ Rare Diseases
November 2021
-
Human-on-a-Chip Approach Validated to Model Rare Autoimmune Disease
Drug Discovery World ∙ 11/30/2021 ∙ Tissue Chip -
Santhera and ReveraGen Announce Positive Topline Results with Vamorolone after Completion of the VISION-DMD Study
Yahoo! ∙ 11/23/2021 ∙ NCATS -
The BGTC is Working to Streamline the Development of Gene Therapies for Rare Diseases
Patient Worthy ∙ 11/23/2021 ∙ Bespoke Gene Therapy Consortium -
Stem Cells Help Researchers Create More Complete Genomic Images of Difficult-to-Study Parts of the Brain That Are Involved in Many Important Functions - ScienceDaily
Jioforme.com ∙ 11/21/2021 ∙ CTSA Program -
Infineon Calls for What Palantir Already Has
Seeking Alpha ∙ 11/19/2021 ∙ CTSA Program -
Franciscan Taking Part in Study of Whether Medications Like Ivermectin Are Eeffective Against COVID
NWI Times ∙ 11/19/2021 ∙ CTSA Program -
The Role of Gene Therapy in Curing Rare Diseases
Raconteur ∙ 11/18/2021 ∙ Rare Diseases -
Chronic Olfactory Loss Plagues Many with COVID-19
TechiLive.in ∙ 11/18/2021 ∙ CTSA Program -
Loyola University Chicago and Lyfebulb Announce the Winners of the 2021 Innovation Challenge
Yahoo! Finance ∙ 11/18/2021 ∙ CTSA Program -
Santhera and ReveraGen Announce Successful FDA Pre-NDA Meeting for Vamorolone in Duchenne Muscular Dystrophy
Globe Newswire ∙ 11/17/2021 ∙ NCATS -
Franciscan Health Michigan City Joins Nationwide Outpatient Study to Test Medications’ Efficacy against Mild-to-Moderate COVID-19
WIMS ∙ 11/17/2021 ∙ CTSA Program -
FDA, NIH, and 15 Private Organizations Join Forces to Increase Effective Gene Therapies for Rare Diseases
Orlando Medical News ∙ 11/17/2021 ∙ Bespoke Gene Therapy Consortium -
ICD Codes and Rare Diseases
CheckRare ∙ 11/16/2021 ∙ Rare Diseases -
Patient-First Approach to Specialty Relieves Eco-nomic Burden, Improves Outcomes, Enhances Quality of Life
Specialty Pharmacy Continuum ∙ 11/16/2021 ∙ GARD -
Evidence That Type 1 Diabetes May Not Be a Single Disease
Naturopathic Doctor News and Review ∙ 11/15/2021 ∙ CTSA Program -
Higher Risk for COVID-19-Related Hospitalization, Death in HIV-Positive Individuals
MDedge ∙ 11/15/2021 ∙ CTSA Program -
Penn State Secures $25M NCATS Renewal with Focus on Data, Health Equity & Research-as-a-Care Option
TrialSite News ∙ 11/14/2021 ∙ CTSA Program -
Biopharma-Academic Collaborations in 2021
Applied Clinical Trials ∙ 11/12/2021 ∙ NCATS -
‘Bespoke Gene Therapy Consortium’ Sets Out to Enable Gene Therapies for Ultra-Rare Diseases
Nature Reviews Drug Discovery ∙ 11/12/2021 ∙ Bespoke Gene Therapy Consortium -
Should Patients With Stable CHD Be Tested for Mental Stress?
Physician’s Weekly ∙ 11/11/2021 ∙ CTSA Program -
Startup Regulonix Pursues Non-Opioid Pain Drug That Indirectly Blocks a Key Ion Channel
FierceBiotech ∙ 11/10/2021 ∙ Division of Preclinical Innovation -
Health Equity: Medical Research with Carol Oladele, PhD, MPH, Eliseo J. Pérez-Stable, MD & Consuelo H. Wilkins, MD, MSCI
The Washington Post ∙ 11/10/2021 ∙ CTSA Program -
Depression Screening at School Ups Odds of Treatment
Futurity ∙ 11/10/2021 ∙ CTSA Program -
bitgrit and CrowdPlat Partner to Host an AI Competition for NCATS
Medium ∙ 11/09/2021 ∙ NCATS -
Mayo Clinic Co-Leads a New Coalition to Improve Patient Care through Community-Level Clinical Trials
Mayo Clinic ∙ 11/09/2021 ∙ NCATS -
Depression - School-based Screening Increases Identification of, Treatment
HealthNewsDigest.com ∙ 11/08/2021 ∙ CTSA Program -
The Labroots 2021 Cancer Research and Oncology Virtual Event Poster Winner
Labroots ∙ 11/05/2021 ∙ CTSA Program -
Watch: A Conversation on Breakthroughs in Rare Disease Diagnosis
Axios Media ∙ 11/04/2021 ∙ Rare Diseases -
AstraZeneca Canada Files for Health Canada Authorization of AZD7442 for Prevention Of COVID-19
Yahoo! Finance ∙ 11/03/2021 ∙ CTSA Program -
NIH Expands Clinical Trials to Test Convalescent Plasma against COVID-19
The World News Monitor ∙ 11/03/2021 ∙ CTSA Program -
Rare Diseases Cost 3 to 5 Times More than Common Diseases
CheckRare ∙ 11/03/2021 ∙ Rare Diseases -
Increasing Effective Gene Therapies For Rare Diseases
Pioneering Minds ∙ 11/02/2021 ∙ Bespoke Gene Therapy Consortium -
Rare Disease Research Was Advanced During COVID-19
Patient Worthy ∙ 11/02/2021 ∙ Division of Preclinical Innovation, RDCRN -
Sanford Joins NIH Study to Raise Awareness about High Health Care Costs for People with Rare Diseases
Med Magazine ∙ 11/02/2021 ∙ Rare Diseases -
A New Era for Translational Research
Applied Clinical Trials ∙ 11/01/2021 ∙ NCATS -
Rare Disease Consortium to Focus on Optimizing AAV Gene Therapies
GeneTherapyLive™ ∙ 11/01/2021 ∙ Bespoke Gene Therapy Consortium
October 2021
-
NIH, FDA and 15 Private Organizations Join Forces to Increase Effective Gene Therapies for Rare Diseases
Mirage News ∙ 10/28/2021 ∙ Bespoke Gene Therapy Consortium -
FDA, NIH Announce Bespoke Gene Therapy Consortium to Focus on Rare Diseases
Newsweek ∙ 10/28/2021 ∙ Bespoke Gene Therapy Consortium -
FDA, NIH, and 15 Partners Advance Gene Therapy Development in Rare Diseases
Targeted Oncology™ ∙ 10/28/2021 ∙ Bespoke Gene Therapy Consortium -
Pfizer, Novartis Sign on to Accelerate Gene Therapies for Rare Diseases with US Agencies
FierceBiotech ∙ 10/28/2021 ∙ Bespoke Gene Therapy Consortium -
A Rare Disease Diagnosis Comes with Significant Health Care Costs, Study Shows
Healio ∙ 10/28/2021 ∙ Rare Diseases -
Public-Private Partnership Launched to Accelerate Gene Therapies for Rare Diseases
STAT ∙ 10/27/2021 ∙ Bespoke Gene Therapy Consortium -
What to Know about Metabolic Disorders
MedicalNewsToday ∙ 10/27/2021 ∙ GARD -
Identification of Long COVID Patients Using Big Data
News-Medical.net ∙ 10/26/2021 ∙ CTSA Program -
Study Suggests People with Rare Diseases Face Significantly Higher Health Care Costs
PHARMABIZ.com ∙ 10/25/2021 ∙ Rare Diseases -
Study Reveals the True Burden of the Hidden Pandemic of Fatty Liver Disease
California News Times ∙ 10/21/2021 ∙ CTSA Program -
Pandemic Research Lays Path Forward for Study of Rare Diseases
MedPage Today ∙ 10/21/2021 ∙ Division of Preclinical Innovation, Rare Diseases -
TEDDY Study Compares Characteristics of Children Diagnosed with Type 1 Diabetes before and after Age 6
Social & Behavioral Science ∙ 10/21/2021 ∙ CTSA Program -
Conditionally Reprogrammed Cells and Robotic High-Throughput Screening for Precision Cancer Therapy
Frontiers in Oncology ∙ 10/19/2021 ∙ Tox21 -
Researchers from Kaiser Permanente Washington Health Research Institute Detail New Studies and Findings in the Area of Health Policy and Technology (Usefulness of Mobile Apps for Communication of Genetic Test Results To At-risk Family Members …): Technolo
Insurance Daily News ∙ 10/19/2021 ∙ CTSA Program -
Bacterial Infections in Sinuses of Cystic Fibrosis Patients Share Surprising Similarities
Science Magazine ∙ 10/19/2021 ∙ CTSA Program -
Study: Protection Conferred by Johnson & Johnson Vaccine Virtually Disappears after 5 Months
The Western Journal ∙ 10/18/2021 ∙ NCATS -
Telehealth Screening of Infants may Help in Early Autism Support
Medindia ∙ 10/17/2021 ∙ CTSA Program -
Officials: Move to Zero Trust Will Look Different for Every Agency
MeriTalk ∙ 10/14/2021 ∙ NCATS -
Hormone Widely Used as an Autism Treatment Shows No Benefit
Science Daily ∙ 10/13/2021 ∙ CTSA Program -
Type 2 Diabetes Drugs May Lessen Severe Covid-19 Risks
Futurity ∙ 10/12/2021 ∙ CTSA Program -
Anticipated Spill from Deteriorating Red Sea Oil Tanker Threatens Public Health
Science Daily ∙ 10/11/2021 ∙ CTSA Program -
Goal-Focused Emotion-Regulation Therapy for Young Adult Testicular Cancer Survivors
The ASCO Post ∙ 10/11/2021 ∙ CTSA Program -
Oncology Fellows Derive the Greatest Benefit from Advanced Research Training
OncLive ∙ 10/10/2021 ∙ CTSA Program -
Neural Network Helps Predict New Drug Combinations to Fight COVID-19
News Binding ∙ 10/09/2021 ∙ Division of Preclinical Innovation -
Ivermectin: Why Are There Lawsuits Over This Unproven Drug
c|net ∙ 10/06/2021 ∙ CTSA Program -
Thousands of Unknown Chemicals and Substances Found in E-Cigarettes
News-Medical.net ∙ 10/06/2021 ∙ CTSA Program -
'Havana Syndrome': A Real and Present Danger
MedPage Today, LLC ∙ 10/05/2021 ∙ NCATS -
NIH Continues Collaboration with Palantir Technologies to Support COVID-19 Research
Yahoo! Finance ∙ 10/04/2021 ∙ CTSA Program -
AI Technology Automates Tedious Cell Culture Work and Analyses
Drug Discovery & Development ∙ 10/01/2021 ∙ Division of Preclinical Innovation -
Merck’s Promising Experimental Covid-19 Drug Raises Hopes for Pill to Fight Virus
POLITICO ∙ 10/01/2021 ∙ Division of Preclinical Innovation -
The Mighty's Lambert-Eaton Myasthenic Syndrome (LEMS) Condition Guide
The Mighty ∙ 10/01/2021 ∙ GARD -
Can Food Ease Symptoms for People with Bipolar Disorders?
Futurity ∙ 10/01/2021 ∙ CTSA Program
September 2021
-
Messy, Incomplete U.S. Data Hobbles Pandemic Response
The Washington Post ∙ 09/30/2021 ∙ NCATS -
A Comparison between Diffuse Idiopathic Skeletal Hyperostosis and Ankylosing Spondylitis
MedicalNewsToday ∙ 09/29/2021 ∙ GARD -
What Happens When the World's Most Popular COVID-19 Dashboard Can't Get Data?
TIME ∙ 09/29/2021 ∙ CTSA Program -
AI Identifies Synergistic Drug Combinations For Treating COVID-19
Pioneering Minds ∙ 09/28/2021 ∙ Division of Preclinical Innovation -
How to Rescue Big Pharma Drug Castoffs from the Scrap Bin through Nonprofit Partnerships: Report
FierceBiotech ∙ 09/27/2021 ∙ New Therapeutic Uses -
Ivermectin and COVID-19: Two Deaths Linked to Use of the Drug in New Mexico
c|net ∙ 09/24/2021 ∙ CTSA Program -
U.S. Dept. of Health and Human Services Taps Draper to Develop Lung-on-a-Chip Technology to Study SARS-CoV-2
Yahoo! Finance ∙ 09/23/2021 ∙ Tissue Chip -
Large Retrospective Study Tracks Use of HCQ, Remdesivir & Dexamethasone in Real-World Settings
TrialSite News ∙ 09/22/2021 ∙ CTSA Program -
Discovery Points toward a New Strategy for Treating Parkinson’s Disease
News-Medical.net ∙ 09/21/2021 ∙ Division of Preclinical Innovation -
Ivermectin and COVID-19: What You Need to Know about This Unproven Drug
c|net ∙ 09/15/2021 ∙ CTSA Program -
Platelets Are Key to Blood Vessel Damage in Patients with COVID-19
ReachMD ∙ 09/14/2021 ∙ CTSA Program -
Mayo, Google Develop a New AI Algorithm to Treat Psychiatric Illness
Gulf Business ∙ 09/14/2021 ∙ CTSA Program -
The Space Summit 2021: Up-to-Date Information on the Deployment of Life Sciences Technologies in Space Aboard the ISS - Boston, United States, September 30th, 2021 - October 1st, 2021
Yahoo! Finance ∙ 09/13/2021 ∙ Tissue Chip
-
Social Determinants of Health Are Important Contributors to Mortality Disparities in U.S., Study Finds
-